Duran, Justine Josh H.
HRN: 07-20-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2023
BENZYL PENICILLIN 5MU (VIAL)
08/17/2023
08/24/2023
IVTT
1,250,000
Q6
Dengue Fever With WS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes